English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine Healthcare & Pharm
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT
Sirnaomics Announces Positive Interim Data from Phase IIb Clinical Trial of STP705 in Adults with Cutaneous Squamous Cell Carcinoma In Situ
Dec 14, 2022 23:15 HKT
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Dec 14, 2022 21:45 HKT
EC Healthcare wins "Best in Healthcare Sector" at IR Magazine's Greater China Awards 2022
Dec 14, 2022 21:38 HKT
Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022
Dec 14, 2022 11:56 HKT
Major Global Medical Device Manufacturer OrbusNeich Medical Group Announces Details of Proposed Listing on the Main Board of HKEX
Dec 13, 2022 10:10 HKT
Polymer protection for vaccines and drugs
Dec 09, 2022 23:00 HKT
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing
Dec 09, 2022 19:27 HKT
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing
Dec 06, 2022 14:00 HKT
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
Dec 06, 2022 11:00 HKT
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
Nov 30, 2022 22:43 HKT
Tianda Pharma Announces 2022/23 Interim Results
Nov 25, 2022 23:54 HKT
JBM Healthcare Announces FY2023 Interim Results
Nov 25, 2022 23:25 HKT
Jacobson Pharma Announces FY2023 Interim Results
Nov 25, 2022 21:21 HKT
EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services
Nov 24, 2022 13:02 HKT
Perfect Medical Announces Interim Results for FY2022/23
Nov 23, 2022 17:30 HKT
Malaysian Genomics Sees Rise in Profit Margins for 1Q
Nov 23, 2022 17:30 HKT
L'Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners, launches SHIHYO, a newly created luxury beauty brand
Nov 21, 2022 08:00 HKT
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally
Nov 18, 2022 20:00 HKT
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 17, 2022 08:00 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: